Patients with Wilson Disease are being recruited for a Pilot study to evaluate brain changes using MRI.
This study is being sponsored by the Wilson Disease Association.
We seek to investigate changes in the brain in patients with Wilson disease using MRI, and to correlate findings with clinical and cognitive assessments. Participation will involve an MRI scan lasting approximately 1 hour, as well as cognitive and neuropsychiatric assessments.
There is only 1 visit required. Total time commitment will be about 2.5 hours.
Reimbursement for your transportation and parking will be up to $100.
To discuss possible participation please contact Yale New-Haven Hospital, Neurology Department by calling 203-785-2185
This intimation is to inform Doctors, Patients, Stockists and Chemists about a shortage of our Brand Cilimin Capsules, (D - Penicillamine IP 250 mg) used for treatment of Wilson's Disease, Rheumatoid Arthritis and other conditions. This happened due to a sudden disruption of supply of raw material of D-Penicillamin by our approved supplier beyond the control of the Company. Since then the company has been working very hard with alternative suppliers for the early resumption of supplies.
With continuous efforts of the Company we are pleased to inform that as of today we expect availability of Cilamin Capsules by end September, 2016.
We regret the inconvenience caused to all in this respect.
Head Supply Chain Management
Panacea Biotec Ltd.
Mobile No: 9816620111
This website is not intended to provide advice on personal medical matters or to substitute for consultation with a physician. The WDA does not accept advertising for this website.
1732 First Avenue #20043. New York, NY. 10128 | 866-961-0533 or 414-961-0533